603567.SS
Heilongjiang ZBD Pharmaceutical Co., Ltd. [603567.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603567.SS Stock Summary
Top 603567.SS Correlated Resources
603567.SS
Top 10 Correlated ETFs
603567.SS
Top 10 Correlated Stocks
603567.SS
In the News
603567.SS Financial details
Company Rating
-
Market Cap
10.32B
Income
507.81M
Revenue
4.33B
Book val./share
-
Cash/share
-
Dividend
0.03
Dividend %
0.24%
Employees
2.76K
Optionable
No
Shortable
Yes
Earnings
27 Oct 2023
P/E
21.74
Forward P/E
-
PEG
5.18
P/S
2.55
P/B
1.46
P/C
-
P/FCF
-199.32
Quick Ratio
2.01
Current Ratio
2.43
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.54
EPS next Y
-
EPS next Q
-
EPS this Y
-47.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-18.02%
Revenue last 5Y
8.66%
Revenue Q/Q
-19.84%
EPS Q/Q
46.44%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-8.33%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.07%
Gross Margin
24%
Oper. Margin
15%
Profit Margin
12%
Payout
34%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.89-17.87
52W High
-36.94%
52W Low
+34%
RSI
50
Rel Volume
1.27
Avg Volume
5.14M
Volume
6.53M
Perf Week
-1.74%
Perf Month
-3.86%
Perf Quarter
-7.75%
Perf Half Y
-11.77%
-
-
-
-
Beta
0.346
-
-
Volatility
0.1%, 0.32%
Prev Close
0%
Price
10.72
Change
3.78%
603567.SS Financial Performance
603567.SS Frequently Asked Questions
What is Heilongjiang ZBD Pharmaceutical Co., Ltd. stock symbol ?
Heilongjiang ZBD Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 603567.SS
What is Heilongjiang ZBD Pharmaceutical Co., Ltd. stock quote today ?
Heilongjiang ZBD Pharmaceutical Co., Ltd. stock price is $10.72 today.
Is Heilongjiang ZBD Pharmaceutical Co., Ltd. stock public?
Yes, Heilongjiang ZBD Pharmaceutical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 5.14M
- Market Capitalization 10.32B
- Employee 2.76K
- CEO Mr. Lei Wang
- Headquarters Hulin,CN
- IPO Date 2015-04-24
-
Website
https://www.zbdzy.com 
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
